Literature DB >> 15023871

C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.

Wolfgang Koenig1, Hannelore Löwel, Jens Baumert, Christa Meisinger.   

Abstract

BACKGROUND: The Framingham Coronary Heart Disease (CHD) prediction score is recommended for global risk assessment in subjects prone to CHD. Recently, C-reactive protein (CRP) has emerged as an independent predictor of CHD. We sought to assess the potential of CRP measurements to enhance risk prediction based on the Framingham Risk Score (FRS) in a large cohort of middle-aged men from the general population. METHODS AND
RESULTS: We measured CRP and traditional cardiovascular risk factors at baseline in 3435 white men of German nationality, 45 to 74 years of age. All men were drawn from 3 random samples of the general population in the Augsburg area located in Southern Germany in 1984 to 1985, 1989 to 1990, and 1994 to 1995 (response rate, 80%), and the FRS was calculated in all of them. Outcome was defined as nonfatal and fatal coronary events, including sudden cardiac death. During an average follow-up of 6.6 years, a total of 191 coronary events occurred. Cox regression showed a significant contribution of CRP to coronary event risk prediction independent of the FRS (P=0.0002). In stratified analysis for 5 categories of FRS, CRP significantly added prognostic information to the FRS in subjects in 2 intermediate risk categories (P=0.03 and P=0.02).
CONCLUSIONS: Our results suggest that CRP enhances global coronary risk as assessed by the FRS, especially in intermediate risk groups. This might have implications for future risk assessment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023871     DOI: 10.1161/01.CIR.0000120707.98922.E3

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  72 in total

1.  Oral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomes.

Authors:  Emily G Kurtz; Paul M Ridker; Lynda M Rose; Nancy R Cook; Brendan M Everett; Julie E Buring; Kathryn M Rexrode
Journal:  Menopause       Date:  2011-01       Impact factor: 2.953

Review 2.  Lipid parameters for measuring risk of cardiovascular disease.

Authors:  Benoit J Arsenault; S Matthijs Boekholdt; John J P Kastelein
Journal:  Nat Rev Cardiol       Date:  2011-02-01       Impact factor: 32.419

3.  Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes.

Authors:  Atif N Qasim; Venkata Budharaju; Nehal N Mehta; Caitlin St Clair; Samira Farouk; Seth Braunstein; Mark Schutta; Nayyar Iqbal; Daniel J Rader; Muredach P Reilly
Journal:  Clin Endocrinol (Oxf)       Date:  2011-01       Impact factor: 3.478

Review 4.  The use of high-sensitivity assays for C-reactive protein in clinical practice.

Authors:  Kiran Musunuru; Brian G Kral; Roger S Blumenthal; Valentin Fuster; Catherine Y Campbell; Ty J Gluckman; Richard A Lange; Eric J Topol; James T Willerson; Milind Y Desai; Michael H Davidson; Samia Mora
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-08-19

5.  Causes and outcomes of markedly elevated C-reactive protein levels.

Authors:  Alexander Landry; Peter Docherty; Sylvie Ouellette; Louis Jacques Cartier
Journal:  Can Fam Physician       Date:  2017-06       Impact factor: 3.275

Review 6.  Effects of exercise on c-reactive protein in healthy patients and in patients with heart disease: A meta-analysis.

Authors:  Tracy L Hammonds; Emily C Gathright; Carly M Goldstein; Marc S Penn; Joel W Hughes
Journal:  Heart Lung       Date:  2016-02-23       Impact factor: 2.210

7.  Neuronal thread protein regulation and interaction with microtubule-associated proteins in SH-Sy5y neuronal cells.

Authors:  S M de la Monte; G J Chen; E Rivera; J R Wands
Journal:  Cell Mol Life Sci       Date:  2003-12       Impact factor: 9.261

Review 8.  Screening low-risk individuals for coronary artery disease.

Authors:  Chintan S Desai; Roger S Blumenthal; Philip Greenland
Journal:  Curr Atheroscler Rep       Date:  2014-04       Impact factor: 5.113

9.  Lipid and C-reactive protein levels, cardiovascular disease risk factors and simvastatin treatment in Brazilian individuals.

Authors:  Alexandre B Rosendo; Luciana O Lima; Felipe Dal-Pizzol; Silvana Almeida
Journal:  Inflammation       Date:  2010-08       Impact factor: 4.092

10.  Metabolically healthy obesity and its associates in Mongolian Chinese adults.

Authors:  Mingzhi Zhang; Weijun Tong; Jing Chen; Yonghong Zhang; Shengxu Li
Journal:  Metab Syndr Relat Disord       Date:  2014-01-24       Impact factor: 1.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.